Safety Study of Pegylated Interferon Alpha 2b to Treat Polycythemia Vera
Status:
Completed
Trial end date:
2018-01-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is the identification of the maximum tolerated dose (MTD) of the
investigational medicinal product. Moreover the safety and tolerability will be assessed and
an exploratory analysis of efficacy and biomarker modulation will be performed.